{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T19:33:15Z","timestamp":1783625595685,"version":"3.55.0"},"reference-count":40,"publisher":"American Medical Association (AMA)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Oncol"],"published-print":{"date-parts":[[2021,10,1]]},"DOI":"10.1001\/jamaoncol.2021.2723","type":"journal-article","created":{"date-parts":[[2021,8,19]],"date-time":"2021-08-19T18:15:20Z","timestamp":1629396920000},"page":"1521","source":"Crossref","is-referenced-by-count":17,"title":["Association of Combined Focal 22q11.22 Deletion and <i>IKZF1<\/i> Alterations With Outcomes in Childhood Acute Lymphoblastic Leukemia"],"prefix":"10.1001","volume":"7","author":[{"given":"David Spencer","family":"Mangum","sequence":"first","affiliation":[{"name":"Nemours\/Alfred I. DuPont Hospital for Children, Division of Pediatric Hematology\/Oncology, Wilmington, Delaware"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia A.","family":"Meyer","sequence":"additional","affiliation":[{"name":"Division of Pediatric Hematology & Oncology, Department of Pediatrics, University of Utah, Salt Lake City"},{"name":"Division of Pediatric Hematology and Oncology, University of California, San Francisco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clinton C.","family":"Mason","sequence":"additional","affiliation":[{"name":"Division of Pediatric Hematology & Oncology, Department of Pediatrics, University of Utah, Salt Lake City"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soheil","family":"Shams","sequence":"additional","affiliation":[{"name":"BioDiscovery, El Segundo, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luke D.","family":"Maese","sequence":"additional","affiliation":[{"name":"Division of Pediatric Hematology & Oncology, Department of Pediatrics, University of Utah, Salt Lake City"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamie D.","family":"Gardiner","sequence":"additional","affiliation":[{"name":"Department of Oncological Sciences, Huntsman Cancer Institute, University of Utah, Salt Lake City"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan M.","family":"Downie","sequence":"additional","affiliation":[{"name":"Department of Medicine, Massachusetts General Hospital, Boston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deqing","family":"Pei","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, St Jude Children\u2019s Research Hospital, Memphis, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Cheng","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, St Jude Children\u2019s Research Hospital, Memphis, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Gleason","sequence":"additional","affiliation":[{"name":"Department of Pathology & Laboratory Medicine, The Children\u2019s Hospital of Philadelphia, Philadelphia, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minjie","family":"Luo","sequence":"additional","affiliation":[{"name":"Department of Pathology & Laboratory Medicine, The Children\u2019s Hospital of Philadelphia, Philadelphia, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ching-Hon","family":"Pui","sequence":"additional","affiliation":[{"name":"Department of Oncology, St Jude Children\u2019s Research Hospital, Memphis, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Aplenc","sequence":"additional","affiliation":[{"name":"Division of Oncology and the Center for Childhood Cancer Research, The Children's Hospital of Philadelphia and The Perelman School of Medicine at the University of Pennsylvania, Philadelphia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen P.","family":"Hunger","sequence":"additional","affiliation":[{"name":"Division of Oncology and the Center for Childhood Cancer Research, The Children's Hospital of Philadelphia and The Perelman School of Medicine at the University of Pennsylvania, Philadelphia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mignon","family":"Loh","sequence":"additional","affiliation":[{"name":"Division of Pediatric Hematology and Oncology, University of California, San Francisco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mel","family":"Greaves","sequence":"additional","affiliation":[{"name":"Institute of Cancer Research, London, England"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolaus","family":"Trede","sequence":"additional","affiliation":[{"name":"JUNO Therapeutics, Seattle, Washington"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Raetz","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, NYU Langone Health, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Kimble","family":"Frazer","sequence":"additional","affiliation":[{"name":"Jimmy Everest Section of Pediatric Hematology-Oncology, Department of Pediatrics, University of Oklahoma Health Sciences Center, Oklahoma City"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles G.","family":"Mullighan","sequence":"additional","affiliation":[{"name":"Department of Pathology, St Jude Children\u2019s Research Hospital, Memphis, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael E.","family":"Engel","sequence":"additional","affiliation":[{"name":"Division of Pediatric Hematology Oncology, Department of Pediatrics, University of Virginia, Charlottesville"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodney R.","family":"Miles","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of Utah Health Sciences Center, Salt Lake City"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen R.","family":"Rabin","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Baylor College of Medicine, Houston, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua D.","family":"Schiffman","sequence":"additional","affiliation":[{"name":"Division of Pediatric Hematology & Oncology, Department of Pediatrics, University of Utah, Salt Lake City"},{"name":"Department of Oncological Sciences, Huntsman Cancer Institute, University of Utah, Salt Lake City"},{"name":"PEEL Therapeutics, Inc, Salt Lake City, Utah"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"4","key":"coi210043r1","doi-asserted-by":"publisher","first-page":"e945","DOI":"10.1542\/peds.2013-3926","article-title":"Cancer incidence rates and trends among children and adolescents in the United States, 2001-2009.","volume":"134","author":"Siegel","year":"2014","journal-title":"Pediatrics"},{"issue":"16","key":"coi210043r2","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1056\/NEJMra1400972","article-title":"Acute lymphoblastic leukemia in children.","volume":"373","author":"Hunger","year":"2015","journal-title":"N Engl J Med"},{"issue":"4","key":"coi210043r3","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1158\/1055-9965.EPI-14-1418","article-title":"Survivors of childhood cancer in the United States: prevalence and burden of morbidity.","volume":"24","author":"Phillips","year":"2015","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"4","key":"coi210043r4","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1111\/bjh.13342","article-title":"Ikaros and leukaemia.","volume":"169","author":"Olsson","year":"2015","journal-title":"Br J Haematol"},{"issue":"5","key":"coi210043r5","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1056\/NEJMoa0808253","article-title":"Deletion of IKZF1 and prognosis in acute lymphoblastic leukemia.","volume":"360","author":"Mullighan","year":"2009","journal-title":"N Engl J Med"},{"issue":"23","key":"coi210043r6","doi-asserted-by":"publisher","first-page":"4874","DOI":"10.1182\/blood-2009-08-239681","article-title":"Identification of novel cluster groups in pediatric high-risk B-precursor acute lymphoblastic leukemia with gene expression profiling: correlation with genome-wide DNA copy number alterations, clinical characteristics, and outcome.","volume":"116","author":"Harvey","year":"2010","journal-title":"Blood"},{"issue":"3","key":"coi210043r7","doi-asserted-by":"publisher","first-page":"428","DOI":"10.3324\/haematol.2011.056135","article-title":"IKZF1 deletion is an independent predictor of outcome in pediatric acute lymphoblastic leukemia treated according to the ALL-BFM 2000 protocol.","volume":"98","author":"D\u00f6rge","year":"2013","journal-title":"Haematologica"},{"issue":"7","key":"coi210043r8","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1038\/leu.2010.87","article-title":"IKZF1 deletions predict relapse in uniformly treated pediatric precursor B-ALL.","volume":"24","author":"Kuiper","year":"2010","journal-title":"Leukemia"},{"issue":"15","key":"coi210043r9","doi-asserted-by":"publisher","first-page":"2622","DOI":"10.1182\/blood-2012-10-462358","article-title":"Independent prognostic value of BCR-ABL1-like signature and IKZF1 deletion, but not high CRLF2 expression, in children with B-cell precursor ALL.","volume":"122","author":"van der Veer","year":"2013","journal-title":"Blood"},{"issue":"9","key":"coi210043r10","doi-asserted-by":"publisher","first-page":"1936","DOI":"10.1038\/leu.2013.92","article-title":"Impact of IKZF1 deletions and PAX5 amplifications in pediatric B-cell precursor ALL treated according to NOPHO protocols.","volume":"27","author":"Ofverholm","year":"2013","journal-title":"Leukemia"},{"issue":"2","key":"coi210043r11","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1038\/leu.2013.206","article-title":"Deletions of IKZF1 and SPRED1 are associated with poor prognosis in a population-based series of pediatric B-cell precursor acute lymphoblastic leukemia diagnosed between 1992 and 2011.","volume":"28","author":"Olsson","year":"2014","journal-title":"Leukemia"},{"issue":"10","key":"coi210043r12","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1002\/pbc.24571","article-title":"IKZF1 and CRLF2 gene alterations correlate with poor prognosis in Japanese BCR-ABL1-negative high-risk B-cell precursor acute lymphoblastic leukemia.","volume":"60","author":"Yamashita","year":"2013","journal-title":"Pediatr Blood Cancer"},{"issue":"2","key":"coi210043r13","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1038\/leu.2012.155","article-title":"Prognostic value of genetic alterations in children with first bone marrow relapse of childhood B-cell precursor acute lymphoblastic leukemia.","volume":"27","author":"Krentz","year":"2013","journal-title":"Leukemia"},{"issue":"12","key":"coi210043r14","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1200\/JCO.2017.74.3617","article-title":"IKZF1plus defines a new minimal residual disease-dependent very-poor prognostic profile in pediatric B-cell precursor acute lymphoblastic leukemia.","volume":"36","author":"Stanulla","year":"2018","journal-title":"J Clin Oncol"},{"issue":"10","key":"coi210043r15","doi-asserted-by":"publisher","first-page":"2204","DOI":"10.1038\/leu.2012.84","article-title":"Outcome in children with Down\u2019s syndrome and acute lymphoblastic leukemia: role of IKZF1 deletions and CRLF2 aberrations.","volume":"26","author":"Buitenkamp","year":"2012","journal-title":"Leukemia"},{"issue":"4","key":"coi210043r16","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1182\/blood.2019000813","article-title":"IKZF1 deletions in pediatric acute lymphoblastic leukemia: still a poor prognostic marker?","volume":"135","author":"Stanulla","year":"2020","journal-title":"Blood"},{"issue":"11","key":"coi210043r17","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1056\/NEJMoa1403088","article-title":"Targetable kinase-activating lesions in Ph-like acute lymphoblastic leukemia.","volume":"371","author":"Roberts","year":"2014","journal-title":"N Engl J Med"},{"issue":"3","key":"coi210043r18","doi-asserted-by":"publisher","first-page":"541","DOI":"10.3324\/haematol.2016.153023","article-title":"Tumor suppressors BTG1 and IKZF1 cooperate during mouse leukemia development and increase relapse risk in B-cell precursor acute lymphoblastic leukemia patients.","volume":"102","author":"Scheijen","year":"2017","journal-title":"Haematologica"},{"issue":"1","key":"coi210043r19","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1038\/leu.2013.277","article-title":"An intragenic ERG deletion is a marker of an oncogenic subtype of B-cell precursor acute lymphoblastic leukemia with a favorable outcome despite frequent IKZF1 deletions.","volume":"28","author":"Clappier","year":"2014","journal-title":"Leukemia"},{"issue":"1","key":"coi210043r20","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1038\/leu.2013.282","article-title":"ERG deletion is associated with CD2 and attenuates the negative impact of IKZF1 deletion in childhood acute lymphoblastic leukemia.","volume":"28","author":"Zaliova","year":"2014","journal-title":"Leukemia"},{"issue":"1","key":"coi210043r21","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1038\/leu.2013.223","article-title":"VPREB1 deletions occur independent of lambda light chain rearrangement in childhood acute lymphoblastic leukemia.","volume":"28","author":"Mangum","year":"2014","journal-title":"Leukemia"},{"issue":"3","key":"coi210043r22","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1182\/blood-2006-01-024729","article-title":"Risk- and response-based classification of childhood B-precursor acute lymphoblastic leukemia: a combined analysis of prognostic markers from the Pediatric Oncology Group (POG) and Children\u2019s Cancer Group (CCG).","volume":"109","author":"Schultz","year":"2007","journal-title":"Blood"},{"issue":"4","key":"coi210043r23","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1002\/pbc.22944","article-title":"Augmented therapy improves outcome for pediatric high risk acute lymphocytic leukemia: results of Children\u2019s Oncology Group trial P9906.","volume":"57","author":"Bowman","year":"2011","journal-title":"Pediatr Blood Cancer"},{"issue":"6","key":"coi210043r24","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1002\/pbc.24420","article-title":"Children\u2019s Oncology Group\u2019s 2013 blueprint for research: acute lymphoblastic leukemia.","volume":"60","author":"Hunger","year":"2013","journal-title":"Pediatr Blood Cancer"},{"issue":"20","key":"coi210043r25","doi-asserted-by":"publisher","first-page":"2380","DOI":"10.1200\/JCO.2015.62.4544","article-title":"Dexamethasone and high-dose methotrexate improve outcome for children and young adults with high-risk B-acute lymphoblastic leukemia: a report from Children\u2019s Oncology Group Study AALL0232.","volume":"34","author":"Larsen","year":"2016","journal-title":"J Clin Oncol"},{"issue":"7137","key":"coi210043r26","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1038\/nature05690","article-title":"Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia.","volume":"446","author":"Mullighan","year":"2007","journal-title":"Nature"},{"issue":"10","key":"coi210043r27","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1038\/leu.2011.128","article-title":"Genomic profiling in Down syndrome acute lymphoblastic leukemia identifies histone gene deletions associated with altered methylation profiles.","volume":"25","author":"Loudin","year":"2011","journal-title":"Leukemia"},{"issue":"1","key":"coi210043r28","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1200\/JCO.1996.14.1.18","article-title":"Uniform approach to risk classification and treatment assignment for children with acute lymphoblastic leukemia.","volume":"14","author":"Smith","year":"1996","journal-title":"J Clin Oncol"},{"key":"coi210043r29","doi-asserted-by":"publisher","first-page":"476","DOI":"10.3389\/fgene.2014.00476","article-title":"Pseudogene-derived lncRNAs: emerging regulators of gene expression.","volume":"5","author":"Milligan","year":"2015","journal-title":"Front Genet"},{"issue":"23","key":"coi210043r30","doi-asserted-by":"publisher","first-page":"2209","DOI":"10.1056\/NEJMoa1516192","article-title":"Genomic classification and prognosis in acute myeloid leukemia.","volume":"374","author":"Papaemmanuil","year":"2016","journal-title":"N Engl J Med"},{"issue":"7","key":"coi210043r31","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1182\/blood-2016-03-704973","article-title":"Integration of genetic and clinical risk factors improves prognostication in relapsed childhood B-cell precursor acute lymphoblastic leukemia.","volume":"128","author":"Irving","year":"2016","journal-title":"Blood"},{"issue":"9","key":"coi210043r32","doi-asserted-by":"publisher","first-page":"2200","DOI":"10.3324\/haematol.2018.207019","article-title":"BCR-ABL1-like acute lymphoblastic leukemia in childhood and targeted therapy.","volume":"105","author":"Cario","year":"2020","journal-title":"Haematologica"},{"issue":"8","key":"coi210043r33","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.3324\/haematol.2012.075432","article-title":"What is the relevance of Ikaros gene deletions as a prognostic marker in pediatric Philadelphia-negative B-cell precursor acute lymphoblastic leukemia?","volume":"98","author":"Palmi","year":"2013","journal-title":"Haematologica"},{"issue":"1","key":"coi210043r34","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1002\/(ISSN)1940-5529","article-title":"Molecular mechanisms and diagnosis of chromosome 22q11.2 rearrangements.","volume":"14","author":"Emanuel","year":"2008","journal-title":"Dev Disabil Res Rev"},{"issue":"5","key":"coi210043r35","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1002\/gcc.v54.5","article-title":"Cooperative genetic changes in pediatric B-cell precursor acute lymphoblastic leukemia with deletions or mutations of IKZF1.","volume":"54","author":"Olsson","year":"2015","journal-title":"Genes Chromosomes Cancer"},{"issue":"10","key":"coi210043r36","doi-asserted-by":"publisher","first-page":"2107","DOI":"10.1038\/leu.2015.78","article-title":"Refinement of IKZF1 status in pediatric Philadelphia-positive acute lymphoblastic leukemia.","volume":"29","author":"Lana","year":"2015","journal-title":"Leukemia"},{"issue":"1","key":"coi210043r37","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1038\/leu.2015.199","article-title":"Prognostic value of rare IKZF1 deletion in childhood B-cell precursor acute lymphoblastic leukemia: an international collaborative study.","volume":"30","author":"Boer","year":"2016","journal-title":"Leukemia"},{"issue":"3","key":"coi210043r38","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.ccell.2015.07.016","article-title":"Efficacy of retinoids in IKZF1-mutated BCR-ABL1 acute lymphoblastic leukemia.","volume":"28","author":"Churchman","year":"2015","journal-title":"Cancer Cell"},{"issue":"4","key":"coi210043r39","doi-asserted-by":"publisher","first-page":"86082","DOI":"10.1172\/jci.insight.86082","article-title":"Synergism of FAK and tyrosine kinase inhibition in Ph+ B-ALL.","volume":"1","author":"Churchman","year":"2016","journal-title":"JCI Insight"},{"issue":"19","key":"coi210043r40","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1200\/JCO.19.00889","article-title":"More is not always better: the perils of treatment intensification in pediatric acute lymphoblastic leukemia.","volume":"37","author":"Hunger","year":"2019","journal-title":"J Clin Oncol"}],"container-title":["JAMA Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamaoncology\/articlepdf\/2783274\/jamaoncology_mangum_2021_oi_210043_1634002290.55104.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,21]],"date-time":"2021-10-21T16:50:25Z","timestamp":1634835025000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamaoncology\/fullarticle\/2783274"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,1]]},"references-count":40,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2021,10,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamaoncol.2021.2723","relation":{},"ISSN":["2374-2437"],"issn-type":[{"value":"2374-2437","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10,1]]}}}